HRP20120743T1 - Novi biomarker za nadzor razvoja bolesti i procjenu uäśinkovitosti lijeäśenja - Google Patents
Novi biomarker za nadzor razvoja bolesti i procjenu uäśinkovitosti lijeäśenja Download PDFInfo
- Publication number
- HRP20120743T1 HRP20120743T1 HRP20120743AT HRP20120743T HRP20120743T1 HR P20120743 T1 HRP20120743 T1 HR P20120743T1 HR P20120743A T HRP20120743A T HR P20120743AT HR P20120743 T HRP20120743 T HR P20120743T HR P20120743 T1 HRP20120743 T1 HR P20120743T1
- Authority
- HR
- Croatia
- Prior art keywords
- disease
- inflammatory
- development
- therapies
- assessing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20070795A FI20070795A0 (fi) | 2007-10-24 | 2007-10-24 | Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin |
| PCT/FI2008/050576 WO2009053523A1 (en) | 2007-10-24 | 2008-10-15 | A new biomarker for monitoring development of diseases and assessing the efficacy of therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120743T1 true HRP20120743T1 (hr) | 2012-10-31 |
Family
ID=38656804
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120743AT HRP20120743T1 (hr) | 2007-10-24 | 2008-10-15 | Novi biomarker za nadzor razvoja bolesti i procjenu uäśinkovitosti lijeäśenja |
| HRP20150181TT HRP20150181T1 (hr) | 2007-10-24 | 2015-02-16 | Cd73 kao biomarker za praä†enje razvoja bolesti i procjenu uäśinkovitosti lijeäśenja |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20150181TT HRP20150181T1 (hr) | 2007-10-24 | 2015-02-16 | Cd73 kao biomarker za praä†enje razvoja bolesti i procjenu uäśinkovitosti lijeäśenja |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20100209942A1 (enExample) |
| EP (2) | EP2201376B1 (enExample) |
| JP (2) | JP4982610B2 (enExample) |
| KR (2) | KR20160029869A (enExample) |
| CA (1) | CA2702635A1 (enExample) |
| CY (2) | CY1113403T1 (enExample) |
| DK (2) | DK2201376T3 (enExample) |
| ES (2) | ES2532361T3 (enExample) |
| FI (1) | FI20070795A0 (enExample) |
| HR (2) | HRP20120743T1 (enExample) |
| PL (2) | PL2201376T3 (enExample) |
| PT (2) | PT2201376E (enExample) |
| SI (2) | SI2201376T1 (enExample) |
| WO (1) | WO2009053523A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| CA2806301A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting cardiovascular diseases or conditions |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
| EA201590024A1 (ru) | 2012-06-15 | 2015-05-29 | Гарри Стилли | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток |
| CN104603289A (zh) | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
| PL2956772T3 (pl) * | 2013-02-14 | 2018-12-31 | Faron Pharmaceuticals Oy | Sposób określenia biomarkerów związanych z zespołem ostrej niewydolności oddechowej (ARDS), sposób monitorowania rozwoju i leczenia ARDS u pacjenta |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
| EP4428251A3 (en) | 2014-09-11 | 2024-12-18 | Immunis.AI, Inc. | Methods of detecting prostate cancer |
| ES2826566T3 (es) | 2014-11-21 | 2021-05-18 | Bristol Myers Squibb Co | Anticuerpos que comprenden regiones constantes pesadas modificadas |
| JP6805142B2 (ja) | 2014-11-21 | 2020-12-23 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｃｄ７３に対する抗体およびその使用 |
| GB201706747D0 (en) | 2017-04-27 | 2017-06-14 | Queen Mary | Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients |
| GB201715115D0 (en) | 2017-09-19 | 2017-11-01 | Univ London Queen Mary | Methods for assessing risk of cardiovascular disease and methods and compounds for use in treating or preventing cardiovascular disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997007236A1 (en) * | 1995-08-18 | 1997-02-27 | Landry Donald W | Detection of organic compounds through regulation of antibody-catalyzed reactions |
| WO1997013875A1 (en) | 1995-10-13 | 1997-04-17 | Imperial College Of Science, Technology & Medicine | Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy |
| HUP0002003A3 (en) | 2000-05-24 | 2003-01-28 | Pronuk Biotechnologia Kft | Process and reagent-kit for determining of 5'-nucleotidase activity |
| CA2439961A1 (en) * | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
| WO2004079013A1 (en) * | 2003-03-03 | 2004-09-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer |
| US7534423B2 (en) * | 2003-03-28 | 2009-05-19 | Faron Pharmaceuticals Oy | Method for inducing an elevated level of adenosine in an individual |
| FI20030467A0 (fi) * | 2003-03-28 | 2003-03-28 | Sirpa Jalkanen | Menetelmä tulehdustilojen hoitamiseen |
| CA2528152A1 (en) * | 2003-06-03 | 2005-01-06 | The Regents Of The University Of California | Compositions and methods for treatment of disease with acetylated disaccharides |
| WO2007025044A2 (en) * | 2005-08-24 | 2007-03-01 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| FI20051003A0 (fi) | 2005-10-07 | 2005-10-07 | Faron Pharmaceuticals Oy | Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi |
| WO2007107598A1 (en) * | 2006-03-21 | 2007-09-27 | Heinrich-Heine-Universität Düsseldorf | Phosphorylated a2a receptor agonists |
| EP3796002B1 (en) * | 2006-07-14 | 2023-11-22 | The Regents of The University of California | Cancer biomarkers and methods of use thereof |
-
2007
- 2007-10-24 FI FI20070795A patent/FI20070795A0/fi not_active Application Discontinuation
-
2008
- 2008-10-15 ES ES12002502.8T patent/ES2532361T3/es active Active
- 2008-10-15 KR KR1020167005473A patent/KR20160029869A/ko not_active Ceased
- 2008-10-15 SI SI200830723T patent/SI2201376T1/sl unknown
- 2008-10-15 PT PT08842581T patent/PT2201376E/pt unknown
- 2008-10-15 KR KR1020107006430A patent/KR20100059902A/ko not_active Ceased
- 2008-10-15 DK DK08842581.4T patent/DK2201376T3/da active
- 2008-10-15 CA CA2702635A patent/CA2702635A1/en not_active Abandoned
- 2008-10-15 HR HRP20120743AT patent/HRP20120743T1/hr unknown
- 2008-10-15 JP JP2010530497A patent/JP4982610B2/ja not_active Expired - Fee Related
- 2008-10-15 EP EP08842581A patent/EP2201376B1/en active Active
- 2008-10-15 WO PCT/FI2008/050576 patent/WO2009053523A1/en not_active Ceased
- 2008-10-15 SI SI200831377T patent/SI2503338T1/sl unknown
- 2008-10-15 PT PT12002502T patent/PT2503338E/pt unknown
- 2008-10-15 DK DK12002502T patent/DK2503338T3/en active
- 2008-10-15 ES ES08842581T patent/ES2389751T3/es active Active
- 2008-10-15 US US12/679,785 patent/US20100209942A1/en not_active Abandoned
- 2008-10-15 PL PL08842581T patent/PL2201376T3/pl unknown
- 2008-10-15 EP EP12002502.8A patent/EP2503338B1/en active Active
- 2008-10-15 PL PL12002502T patent/PL2503338T3/pl unknown
-
2012
- 2012-04-23 JP JP2012098081A patent/JP5619810B2/ja not_active Expired - Fee Related
- 2012-10-04 CY CY20121100924T patent/CY1113403T1/el unknown
-
2015
- 2015-02-16 HR HRP20150181TT patent/HRP20150181T1/hr unknown
- 2015-03-06 CY CY20151100234T patent/CY1116089T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100059902A (ko) | 2010-06-04 |
| JP2012159514A (ja) | 2012-08-23 |
| CY1113403T1 (el) | 2016-06-22 |
| ES2389751T3 (es) | 2012-10-31 |
| PL2201376T3 (pl) | 2013-01-31 |
| EP2201376A1 (en) | 2010-06-30 |
| DK2503338T3 (en) | 2015-03-09 |
| PT2503338E (pt) | 2015-03-05 |
| JP4982610B2 (ja) | 2012-07-25 |
| EP2503338A3 (en) | 2013-03-13 |
| EP2201376B1 (en) | 2012-08-08 |
| PT2201376E (pt) | 2012-08-20 |
| CY1116089T1 (el) | 2017-02-08 |
| JP2011501176A (ja) | 2011-01-06 |
| SI2503338T1 (sl) | 2015-06-30 |
| EP2503338B1 (en) | 2014-12-24 |
| KR20160029869A (ko) | 2016-03-15 |
| US20100209942A1 (en) | 2010-08-19 |
| HRP20150181T1 (hr) | 2015-06-19 |
| ES2532361T3 (es) | 2015-03-26 |
| EP2503338A2 (en) | 2012-09-26 |
| PL2503338T3 (pl) | 2015-06-30 |
| SI2201376T1 (sl) | 2012-09-28 |
| EP2201376A4 (en) | 2011-03-23 |
| FI20070795A0 (fi) | 2007-10-24 |
| DK2201376T3 (da) | 2012-10-15 |
| JP5619810B2 (ja) | 2014-11-05 |
| WO2009053523A1 (en) | 2009-04-30 |
| CA2702635A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lopes et al. | Acute kidney injury in HCT: an update | |
| Moresco et al. | Diabetic nephropathy: traditional to proteomic markers | |
| Fernández et al. | Management of bacterial infections in cirrhosis | |
| EA201290629A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| KR100971305B9 (ko) | 신장 질환용 진단 표지로서의 호중구 젤라티나제 결합리포칼린 의 측정 | |
| JP2011501176A5 (enExample) | ||
| RU2009139295A (ru) | Биомаркеры и биомаркерные признаки почечной сохранности, обладающие предсказательной силой, для использования в мониторинге состояния почек | |
| Wang et al. | Risk factors for mortality in patients with septic acute kidney injury in intensive care units in Beijing, China: a multicenter prospective observational study | |
| Fernandez et al. | Systematic phenotyping and correlation of biomarkers with lung function and histology in lung fibrosis | |
| Henderson et al. | Effects of tyrosine kinase inhibitors on rat isolated heart function and protein biomarkers indicative of toxicity | |
| JP2016505506A5 (enExample) | ||
| EA201290627A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| Mari et al. | Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face | |
| JP2010502979A5 (enExample) | ||
| Schiffl et al. | Urinary biomarkers and acute kidney injury in children: the long road to clinical application | |
| Clermonta et al. | Recovery from acute kidney injury: determinants and predictors | |
| JP2016512325A5 (enExample) | ||
| JP2015523364A5 (enExample) | ||
| WO2014151079A8 (en) | Ratio based biomarkers and methods of use thereof for the detection and prognosis of cancer | |
| EP4330409A4 (en) | GENE THERAPIES FOR STARGARDT'S DISEASE (ABCA4) | |
| JP2012524884A5 (enExample) | ||
| JP2009520696A5 (enExample) | ||
| UA105621U (uk) | Спосіб ранньої діагностики субклінічного ураження нирок у хворих на хронічну серцеву недостатність ішемічного ґенезу | |
| Todorov et al. | Recent advances on renoprotection and kidney regeneration | |
| Knightly et al. | D41 COPD: BIOMARKERS IN STABLE DISEASE AND EXACERBATIONS: Urinary Biomarkers Implicate Proteinase Activity In Acute Exacerbations Of Chronic Obstructive Pulmonary Disease (COPD) |